ESC 365 - Timing of stroke risk reassessment in atrial fibrillation patients with CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study

ESC2025 Premium Access

Timing of stroke risk reassessment in atrial fibrillation patients with CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study

Session: The atrial fibrillation anticoagulation puzzle: putting the pieces together

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor M. Anjum (Baerum, NO)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Mariam Anjum

Baerum Hospital, Baerum (Norway)

0 follower

7 more presentations in this session

Peridevice leak and device-related thrombus in the OPTION randomized trial

Speaker: Doctor O. wazni (Cleveland, US)

Impact of anaemia on OAC prescription and adverse outcomes in patients with AF and chronic HF: an analysis form a real-world observational prospective study

Speaker: Doctor M. Vitolo (Modena, IT)

Discontinuation of oral anticoagulation and risk of worse clinical outcomes in atrial fibrillation patients: a report from the Murcia AF Project III

Speaker: Doctor J. Rivera-Caravaca (Murcia, ES)

Impact of Clinical Complexity Features on the Risk of Major Bleeding and Subsequent Outcomes in Atrial Fibrillation Patients: A Multistate Model analysis from Two Large Observational Registries

Speaker: Doctor D. Mei (Modena, IT)

Comparative in-hospital outcomes of acute ischemic stroke by preexisting atrial flutter or atrial fibrillation, stratified by CHADSVA score

Speaker: Doctor A. Folman (Hadera, IL)

Access the full session

The atrial fibrillation anticoagulation puzzle: putting the pieces together

Speakers: Doctor M. Anjum, Doctor O. wazni, Doctor M. Vitolo, Doctor J. Rivera-Caravaca, Doctor D. Mei...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources